Agios Pharmaceuticals, Inc. (LON:0HB0)
London
· Delayed Price · Currency is GBP · Price in USD 34.74
+1.03 (3.06%)
At close: Feb 21, 2025
Agios Pharmaceuticals Revenue
In the year 2024, Agios Pharmaceuticals had annual revenue of $36.50M USD with 36.07% growth. Agios Pharmaceuticals had revenue of $10.73M in the quarter ending December 31, 2024, with 51.06% growth.
Revenue
$36.50M
Revenue Growth
+36.07%
P/S Ratio
n/a
Revenue / Employee
$74.79K
Employees
488
Market Cap
1.60B GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| Hikma Pharmaceuticals | 2.39B |
| ConvaTec Group | 1.74B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |
Agios Pharmaceuticals News
- 8 days ago - BB Biotech AG Reduces Stake in Agios Pharmaceuticals Inc. - GuruFocus
- 8 days ago - Agios Pharmaceuticals: Liver Toxicity Issues May Threaten Thalassemia Approval (Rating Downgrade) - Seeking Alpha
- 10 days ago - Agios Pharmaceuticals targets multi-billion-dollar growth with Pyrukynd expansion in 2025 - Seeking Alpha
- 10 days ago - Agios Pharmaceuticals, Inc. (AGIO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Agios Pharmaceuticals, Inc. 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 10 days ago - Agios Pharmaceuticals Q4 2024 Earnings: EPS Matches Estimate at -$1. ... - GuruFocus
- 10 days ago - Agios Pharmaceuticals reports Q4 results - Seeking Alpha
- 10 days ago - Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewsWire